文献速递类风湿关节炎

早期类风湿关节炎中的中性粒细胞减少:频率、预测因素、自然史与结局

Neutropaenia in early rheumatoid arthritis: frequency, predicting factors, natural history and outcome.
PubMed 文献 · RMD Open · 2018-10-08

苏格兰早期类风湿关节炎起始队列前瞻性随访771例新诊断RA患者,58例(7.5%)出现中性粒细胞减少,多为轻度、一过性,未增加感染率;女性、非吸烟及基线中性粒细胞较低者更易发生。

要点

  • 早期RA中性粒细胞减少多为1级且为一过性,感染率未增加。
  • 女性、非吸烟、基线中性粒细胞偏低是中性粒细胞减少的相关因素。
  • 部分患者因中性粒细胞减少而停药,需关注治疗管理影响。

核心结论

  • 早期RA中中性粒细胞减少较常见,通常轻微、一过性,且与感染率升高无关。
  • 其发生与女性、非吸烟及较低基线中性粒细胞水平相关。

研究设计与样本

  • 苏格兰早期类风湿关节炎起始队列前瞻性招募新诊断RA患者,每6个月随访一次。
  • 将发生至少一次中性粒细胞减少(1级<2.0×10^9/L;2级<1.5×10^9/L;3级<1.0×10^9/L;4级<0.5×10^9/L)的患者与未发生者比较,并在发生者内部及不同分级间比较。
  • 771例RA患者中58例(7.5%)记录到77次中性粒细胞减少发作,中位随访18(范围6-48)个月。

主要发现

  • 中性粒细胞减少发生于RA诊断后中位12(范围0-120)个月。
  • 多数为轻度:1级n=42、2级n=14、3级n=1、4级n=1。
  • 多数(44例,75.8%)为单次一过性发作,但14例(24.1%)因此停药。
  • 发生者更可能为女性(p=0.01)、非吸烟者(p=0.007)且基线中性粒细胞更低(p<0.0001)。
  • 二项回归分析证实基线中性粒细胞较低为预测因素(p<0.0001,B:-0.491);感染者率在发生与未发生者间无差异(p=0.878)。

关键数值与推荐

  • 中性粒细胞减少分级:1级<2.0×10^9/L;2级<1.5×10^9/L;3级<1.0×10^9/L;4级<0.5×10^9/L。
  • 58/771例(7.5%)发生中性粒细胞减少,共77次发作。
  • 停药发生于14/58例(24.1%)。

临床怎么用

  • 对早期RA女性、非吸烟及基线中性粒细胞偏低者应关注中性粒细胞变化。
  • 多数中性粒细胞减少轻微且一过性,可结合感染风险与停药影响进行个体化管理。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the frequency, severity and natural history of neutropaenia in early rheumatoid arthritis (RA), explore its associations with clinical features and assess its impact on clinical management. METHODS: The Scottish Early Rheumatoid Arthritis inception cohort prospectively recruited patients with newly diagnosed RA and followed them up every 6 months. Patients with RA who developed at least one episode of neutropaenia (grade 1: <2.0×10^9/L; grade 2: <1.5×10^9/L; grade 3: <1.0×10^9/L; grade 4: <0.5×10^9/L) were compared with those who did not. Comparisons were also made between patients who experienced one or more episodes of neutropaenia and between patients with different neutropaenia grades. RESULTS: 77 neutropaenia episodes were recorded in 58 of 771 (7.5%) patients with RA, who were followed up for a median (range) of 18 (6-48) months. Neutropaenia occurred at a median (range) of 12 (0-120) months after RA diagnosis. The majority had mild neutropaenia (grade 1: n=42; grade 2: n=14; grade 3: n=1; grade 4: n=1). Neutropaenia was transient (single episode) in the majority (44; 75.8%) of cases but led to treatment discontinuation in 14 (24.1%) patients. Patients who developed neutropaenia were more likely to be female (p=0.01) and non-smokers (p=0.007) and had lower baseline neutrophil levels (p<0.0001). Binomial regression analysis confirmed the latter (p<0.0001, B: -0.491) as neutropaenia predictor. The rate of infections did not differ between patients who developed neutropaenia and those who did not (p=0.878). CONCLUSION: Neutropaenia was a common finding in this cohort. It was usually mild, transient and not associated with increased infection rates. Neutropaenia occurrence was associated with non-smoking, female gender and lower baseline neutrophil levels.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Fragoulis GE, Paterson C, Gilmour A, et al. Neutropaenia in early rheumatoid arthritis: frequency, predicting factors, natural history and outcome. RMD Open. 2018. PMID: 30402267. doi:10.1136/rmdopen-2018-000739

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。